Select Page

South Delhi Pharma, New Delhi, India

BLENREP (belantamab mafodotin-blmf) for injection

(46 customer reviews)

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

BLENREP is a prescription medicine. BLENREP is used to treat blood cancer called multiple myeloma.
INDICATIONS AND USAGE
BLENREP is a B-cell maturation antigen (BCMA)-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least 4 prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent. This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).
DOSAGE FORMS & STRENGTHS
For injection: 100 mg as a lyophilized powder in a single-dose vial for reconstitution and further dilution.
Manufactured By: GlaxoSmithKline
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “BLENREP (belantamab mafodotin-blmf) for injection” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

Belantamab mafodotin, sold under the brand name Blenrep, is a medication for the treatment of relapsed and refractory multiple myeloma. Belantamab mafodotin was approved for medical use in the United States and in the European Union in August 2020.

Belantamab mafodotin is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior therapies including an anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent.

46 reviews for BLENREP (belantamab mafodotin-blmf) for injection

  1. Ann

  2. Ronald

  3. Yvette

  4. Wilfredo

  5. Lindsey

  6. Eloy

  7. Deena

  8. Stacia

  9. Palma

  10. Brook

  11. Marylou

  12. Jarred

  13. Latoya

  14. InessaOlmr

    coursework writing uk
    [url=”https://brainycoursework.com”]coursework science[/url]
    coursework writers

  15. Bertha

  16. Becky

  17. Clemmie

  18. Gus

  19. Margie

  20. Miguel

  21. Lucienne

  22. Geraldine

  23. Chara

  24. Twyla

  25. Rosalyn

  26. Jonnie

  27. Lashonda

  28. Susanna

  29. Dawn

  30. Lydia

  31. Gordon

  32. Grady

  33. Mickey

  34. Roxanne

  35. Laurene

  36. Brent

  37. Chana

  38. Guy

  39. Starla

  40. emultetly

    Interpretation of ascites fluid tests online cialis pharmacy Your friend who is TTC would welcome a professional rubdown that melts her tension away, if only temporarily, and massage feels so much better when you re not footing the bill

  41. emultetly

    For this analysis, we excluded patients with missing data needed to calculate CTS5, leading to a sample size of 1301 women uk lasix 49 14 blastocyst adj2 transfer

  42. Giselle

Add a review

Your email address will not be published. Required fields are marked *